Table 1.
Clinicopathologic characteristics of the cohort.
| Clinicopathologic characteristic | No. of patients (%) (N=153) |
|---|---|
|
| |
| Age at diagnosis | |
| Median (range), years | 65 (30–89) |
| BMI at diagnosis | |
| Median (range), kg/m2 | 25.3 (16–65.4) |
| FIGO stage at diagnosis | |
| III | 88 (58) |
| IV | 65 (42) |
| BRCA mutation (germline and somatic) | |
| BRCA 1 | 20 (13.1) |
| BRCA 2 | 6 (3.9) |
| Wildtype | 96 (62.7) |
| Unknown | 31 (20.3) |
| Histology | |
| High-grade serous | 126 (82.3) |
| Low-grade serous | 4 (2.6) |
| Clear cell | 5 (3.3) |
| Mucinous | 2 (1.3) |
| Low-grade endometroid | 1 (0.7) |
| Carcinosarcoma | 6 (3.9) |
| Other* | 9 (5.9) |
*
Mixed histology, treated with cytology only, subtype not classified
BMI, body mass index; FIGO, International Federation of Gynecology and Obstetrics